Pharmacology Research Institute Competitors and Similar CompaniesClear all

Pharmacology Research Institute's competitors and similar companies include Medpace, Accellacare UK, Anacura and Parexel International.

	Pharmacology Research Institute Pharmacology Research Institute (PRI) is a scientific research organization specializing in pharmacological and multidisciplinary studies for pharmaceutical companies.	Medpace Medpace is a clinical contract research organization (CRO).	Accellacare UK Accellacare UK (formerly known as MeDiNova Research) is a clinical research company that provides clinical trial services.	Anacura Anacura is an independent analytical center, active in healthcare and life sciences.	Parexel International Parexel International (MA) is a clinical research organization.
Founding Date	Founding Date 1975	Founding Date 1992	Founding Date 1997	Founding Date 1985	Founding Date 1982
Type	Type Private	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma
Locations	Locations Los Alamitos, US HQ Los Angeles, US Newport Beach, US	Locations Cincinnati, US HQ Buenos Aires, AR South Yarra, AU Leuven, BE Leuven, BE Sao Paulo, BR Toronto, CA see more	Locations Coventry, GB HQ	Locations Evergem, BE HQ	Locations Newton, US HQ Olivos, AR Vicente López, AR Brisbane, AU Macquarie Park, AU Wavre, BE Sao Paulo, BR see more
Employees	Employees 8	Employees 5,90013% increase	Employees 2433% increase	Employees 1201% decrease	Employees 20,806
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2.1b (FY, 2024)	Revenue (est.) £9.4m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $1.5b (FY, 2024)	Cost of goods £1.6m (FY, 2021)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $656.3m (FY, 2024)	Gross profit £7.8m (FY, 2021)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income $404.4m (FY, 2024)	Net income £742.9k (FY, 2021)	Net income N/A	Net income N/A
Operating ⚠
Backlog	Backlog N/A	Backlog $2.7b (Q3, 2023)	Backlog N/A	Backlog N/A	Backlog $4b (FY, 2017)
Countries	Countries N/A	Countries 40 (Q3, 2023)	Countries 55 (Apr, 2023)	Countries N/A	Countries 52 (FY, 2017)